Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated sponsor/collaborator naming to Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Removed the former names Sidney Kimmel Cancer Center at Thomas Jefferson University and the parenthetical Thomas Jefferson University (Sidney Kimmel Cancer Center at Thomas Jefferson University).SummaryDifference0.3%

- Check34 days agoChange DetectedThe page adds a new Revision: v3.4.2 and removes an older funding-status notice and Revision: v3.4.1; these are administrative updates that do not alter trial details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a government funding notice and a site revision (v3.4.1); removed the prior revision (v3.4.0); core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdministrative updates to page metadata and UI elements, including adding a glossary display, and updating revision/version indicators while removing outdated metadata terms. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedFooter now shows Revision: v3.3.4, replacing v3.3.3. No study data or key information were modified.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.